全球宠物肿瘤药物市场：市场规模、疗法、给药途径、生物类型、应用、行业分析报告、区域展望、增长潜力、价格趋势、竞争性市场份额和预测，2023-2032 年

由于宠物护理成本激增，全球宠物抗癌药物市场预计到 2032 年将显着增长。

此外，动物主人对动物健康和福利的认识不断提高，进一步推动了该行业的发展。

由于淋巴瘤和黑色素瘤等癌症在宠物中的发病率呈上升趋势，因此全球对宠物癌症治疗药物的需求正在扩大。 随着宠物主人越来越多地在动物保健上花钱，对宠物癌症治疗的需求也越来越大，尤其是在发达国家。

此外，行业参与者正在通过战略合作伙伴关係和协作来巩固其市场地位。 例如，2021 年 6 月，勃林格殷格翰和 WEHI 宣布合作，通过协调的蛋白水解机制发现和设计抗癌疗法。 这种伙伴关係使我们能够结合我们在生物学、治疗靶点、蛋白水解和药物发现方面的知识，专注于致癌蛋白。

宠物抗癌药物市场根据治疗、给药途径、物种、应用和地理区域进行细分。

基于治疗，到 2032 年，靶向治疗领域的市场估值预计将超过 1.63 亿美元。 个性化医疗的流行和当前的进步是支持该领域发展的主要因素。 此外，宠物肿瘤的研发能力有望提升各公司的潜力。 预计这些发展将显着加速市场扩张。

通过应用，黑色素瘤面积有望在研究期间显着增长。 宠物黑色素瘤病例激增已成为推动业务增长的主要渲染因素。 根据美国国家生物技术信息中心 (NCBI) 的数据，犬类黑色素瘤在 2017 年占犬类所有口腔癌的 14.4% 至 45.5%，被认为是最常见的口腔恶性肿瘤。

由于宠物癌症患病率上升和宠物护理成本飙升，预计到 2032 年亚太地区宠物癌症治疗市场的价值将超过 4700 万美元。. 据2020年中国宠物行业统计，全国宠物犬存栏量超过5222万隻。 肿瘤也是宠物犬的常见病，患病率为0.282%～1.701%。

内容

第 1 章研究方法和范围

第 2 章执行摘要

第 3 章：宠物抗癌药物的行业洞察

• 2018-2032 年行业形势变化
• 影响行业的因素
  • 司机
    • 宠物癌症增加
    • 提高宠物主人对宠物疾病的认识
    • 宠物护理支出增加
    • 宠物癌症治疗药物的技术进步，包括癌症免疫疗法
    • 高度未满足的医疗需求和巨大的潜力
  • 行业潜在的风险和挑战
    • 与宠物抗癌药物相关的副作用
    • 兽医肿瘤学家短缺
• 增长分析
  • 通过治疗
  • 按给药途径
  • 按事件
  • 通过申请
• COVID-19 影响分析
• 产品管道分析
• 监管状况
  • 美国
  • 欧盟
  • 巴西
  • 澳大利亚
  • 印度
• 差距分析
• 波特分析
• PESTLE 分析

第 4 章竞争格局，2021 年

• 介绍
• 2021 年公司矩阵分析
• 战略仪表板，2021 年

第 5 章宠物抗癌药物市场：按治疗分类

• 主要治疗趋势
• 化疗
• 免疫疗法
• 靶向治疗
• 联合疗法

第 6 章宠物抗癌药市场：按给药途径分类

• 主要给药途径的趋势
• 口语
• 注射

第 7 章宠物抗癌药物市场：按生物体分类

• 主要物种的趋势
• 狗
• 猫

第 8 章宠物抗癌药物市场：按应用

• 主要应用趋势
• 淋巴瘤
• 肥大细胞瘤
• 黑色素瘤
• 乳腺癌/鳞状细胞癌
• 其他

第 9 章宠物癌症治疗市场：按地区

• 主要区域趋势
• 北美
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 意大利
  • 瑞典
  • 瑞士
  • 荷兰
  • 奥地利
  • 波兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 菲律宾
  • 新西兰
• 拉丁美洲
  • 巴西
  • 墨西哥

第十章公司简介

• Zoetis, Inc.
• Elanco Animal Health
• Boehringer Ingelheim International GmbH
• Dechra Pharmaceuticals
• AB Science
• Qbiotics
• NovaVive, Inc.
• ELIAS Animal Health

Global Pet Cancer Therapeutics Market is speculated to grow considerably through 2032 owing to the surging pet care expenses. Moreover, the rising awareness among pet owners regarding the health and well-being of animals has further bolstered industry growth.

The demand for pet cancer therapies is expanding globally due to the rising prevalence of pet cancers including lymphoma and melanoma, among many others. Also, the growing propensity of pet owners to spend money on animal healthcare is raising the need for cancer treatments for pets, particularly in industrialized nations.

In addition, the leading industry players are seeking to strengthen their position in the market through strategic partnership and collaboration. For instance, in June 2021, Boehringer Ingelheim and WEHI announced their partnership to explore and design anti-cancer therapies via a tailored protein degradation mechanism. The alliance enabled the firm to combine its knowledge of biology, therapeutic targeting, protein degradation, and drug discovery to focus on cancer-causing proteins.

The pet cancer therapeutics market has been divided in terms of therapy, route of administration, species, application, and region.

Based on therapy, the targeted therapy segment is expected to amass more than USD 163 million in market valuation by 2032. The rising use of personalized therapy and current advances are the primary drivers behind robust segmental growth. Additionally, it is anticipated that pet oncology R&D capabilities will improve the various companies' potential. Those developments are predicted to significantly accelerate market expansion.

With respect to application, the melanoma segment is set to attain sizable growth over the review period. The upsurge in melanoma cases amongst pets is the key rendering factor fueling business growth. According to the National Centers for Biotechnology Information (NCBI), canine melanoma, which made up 14.4% to 45.5% of all oral cancers in dogs in 2017, was thought to be the most common oral malignancy.

From the regional outlook, the Asia Pacific pet cancer therapeutics market is estimated to surpass over USD 47 million valuation by 2032 attributed to the increased prevalence of cancer among pets as well the skyrocketing pet care costs in the region. As per the statistics on China's pet industry in 2020, the pet dog adoption in the country has exceeded 52.22 million. Moreover, tumor has stood as a common disease in pet dog, with prevalence ranging from 0.282% to 1.701%.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Methodology
• 1.2 Market scope & definitions
• 1.3 Base estimates and working
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact analysis at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Pet cancer therapeutics industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Therapy trends
  • 2.1.3 Route of administration trends
  • 2.1.4 Species trends
  • 2.1.5 Applications trends
  • 2.1.6 Regional trends

Chapter 3 Pet Cancer Therapeutics Industry Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of pet cancer
    • 3.2.1.2 Growing awareness among pet owners regarding pet diseases
    • 3.2.1.3 Increasing pet care expenditure
    • 3.2.1.4 Technological advancements in pet cancer therapeutics including cancer immunotherapy
    • 3.2.1.5 High medical unmet need and strong potential
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Side effects associated with pet cancer therapeutics
    • 3.2.2.2 Lack of veterinary oncologists
• 3.3 Growth potential analysis
  • 3.3.1 By therapy
  • 3.3.2 By route of administration
  • 3.3.3 By species
  • 3.3.4 By application
• 3.4 COVID- 19 impact analysis
• 3.5 Product pipeline analysis
• 3.6 Regulatory landscape
  • 3.6.1 U.S.
  • 3.6.2 European Union
  • 3.6.3 Brazil
  • 3.6.4 Australia
  • 3.6.5 India
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTLE analysis

Chapter 4 Competitive landscape, 2021

• 4.1 Introduction
• 4.2 Company matrix analysis, 2021
• 4.3 Strategy dashboard, 2021

Chapter 5 Pet Cancer Therapeutics Market, By Therapy

• 5.1 Key therapy trends
• 5.2 Chemotherapy
  • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.3 Immunotherapy
  • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.4 Targeted therapy
  • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.5 Combination therapy
  • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Pet Cancer Therapeutics Market, By Route of Administration

• 6.1 Key route of administration trends
• 6.2 Oral
  • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.3 Injection
  • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Pet Cancer Therapeutics Market, By Species

• 7.1 Key species trends
• 7.2 Dogs
  • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.3 Cats
  • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Pet Cancer Therapeutics Market, By Application

• 8.1 Key application trends
• 8.2 Lymphoma
  • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.3 Mast cell cancer
  • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.4 Melanoma
  • 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.5 Mammary and squamous cell cancer
  • 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.6 Others
  • 8.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Pet Cancer Therapeutics Market, By Region

• 9.1 Key regional trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Sweden
  • 9.3.7 Switzerland
  • 9.3.8 The Netherlands
  • 9.3.9 Austria
  • 9.3.10 Poland
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Philippines
  • 9.4.7 New Zealand
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico

Chapter 10 Company Profiles

• 10.1 Zoetis, Inc.
• 10.2 Elanco Animal Health
• 10.3 Boehringer Ingelheim International GmbH
• 10.4 Dechra Pharmaceuticals
• 10.5 AB Science
• 10.6 Qbiotics
• 10.7 NovaVive, Inc.
• 10.8 ELIAS Animal Health

DATA TABLES

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by therapy
• TABLE 3 Market revenue, by route of administration
• TABLE 4 Market revenue, by species
• TABLE 5 Market revenue, by application
• TABLE 6 Market revenue, by region
• TABLE 7 Global pet cancer therapeutics market, 2018 - 2022 (USD Million)
• TABLE 8 Global pet cancer therapeutics market, 2023 - 2032 (USD Million)
• TABLE 9 Global pet cancer therapeutics market, by therapy, 2018 - 2022 (USD Million)
• TABLE 10 Global pet cancer therapeutics market, by therapy, 2023 - 2032 (USD Million)
• TABLE 11 Global pet cancer therapeutics market, by route of administration, 2018 - 2022 (USD Million)
• TABLE 12 Global pet cancer therapeutics market, by route of administration, 2023 - 2032 (USD Million)
• TABLE 13 Global pet cancer therapeutics market, by species, 2018 - 2022 (USD Million)
• TABLE 14 Global pet cancer therapeutics market, by species, 2023 - 2032 (USD Million)
• TABLE 15 Global pet cancer therapeutics market, by application, 2018 - 2022 (USD Million)
• TABLE 16 Global pet cancer therapeutics market, by application, 2023 - 2032 (USD Million)
• TABLE 17 Global pet cancer therapeutics market, by region, 2018 - 2022 (USD Million)
• TABLE 18 Global pet cancer therapeutics market, by region, 2023 - 2032 (USD Million)
• TABLE 19 Industry impact forces
• TABLE 20 Chemotherapy market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 21 Chemotherapy market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 22 Immunotherapy market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 23 Immunotherapy market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 24 Targeted therapy market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 25 Targeted therapy market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 26 Combined therapy market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 27 Combined therapy market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 28 Oral market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 29 Oral market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 30 Injection market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 31 Injection market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 32 Dogs market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 33 Dogs market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 34 Cats market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 35 Cats market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 36 Lymphoma market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 37 Lymphoma market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 38 Mast cell cancer market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 39 Mast cell cancer market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 40 Melanoma market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 41 Melanoma market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 42 Mammary and squamous cell cancer market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 43 Mammary and squamous cell cancer market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 44 Others market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 45 Others market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 46 North America pet cancer therapeutics market, by country, 2018 - 2022, (USD Million)
• TABLE 47 North America pet cancer therapeutics market, by country, 2023 - 2032, (USD Million)
• TABLE 48 North America pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 49 North America pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 50 North America pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 51 North America pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 52 North America pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 53 North America pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 54 North America pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 55 North America pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 56 U.S. pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 57 U.S. pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 58 U.S. pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 59 U.S. pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 60 U.S. pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 61 U.S. pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 62 U.S. pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 63 U.S. pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 64 Canada pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 65 Canada pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 66 Canada pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 67 Canada pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 68 Canada pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 69 Canada pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 70 Canada pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 71 Canada pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 72 Europe pet cancer therapeutics market, by country, 2018 - 2022, (USD Million)
• TABLE 73 Europe pet cancer therapeutics market, by country, 2023 - 2032, (USD Million)
• TABLE 74 Europe pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 75 Europe pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 76 Europe pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 77 Europe pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 78 Europe pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 79 Europe pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 80 Europe pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 81 Europe pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 82 Germany pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 83 Germany pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 84 Germany pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 85 Germany pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 86 Germany pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 87 Germany pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 88 Germany pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 89 Germany pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 90 UK pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 91 UK pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 92 UK pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 93 UK pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 94 UK pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 95 UK pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 96 UK pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 97 UK pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 98 France pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 99 France pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 100 France pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 101 France pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 102 France pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 103 France pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 104 France pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 105 France pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 106 Spain pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 107 Spain pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 108 Spain pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 109 Spain pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 110 Spain pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 111 Spain pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 112 Spain pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 113 Spain pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 114 Italy pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 115 Italy pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 116 Italy pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 117 Italy pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 118 Italy pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 119 Italy pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 120 Italy pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 121 Italy pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 122 Sweden pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 123 Sweden pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 124 Sweden pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 125 Sweden pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 126 Sweden pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 127 Sweden pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 128 Sweden pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 129 Sweden pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 130 Switzerland pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 131 Switzerland pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 132 Switzerland pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 133 Switzerland pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 134 Switzerland pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 135 Switzerland pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 136 Switzerland pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 137 Switzerland pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 138 The Netherlands pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 139 The Netherlands pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 140 The Netherlands pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 141 The Netherlands pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 142 The Netherlands pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 143 The Netherlands pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 144 The Netherlands pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 145 The Netherlands pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 146 Austria pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 147 Austria pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 148 Austria pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 149 Austria pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 150 Austria pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 151 Austria pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 152 Austria pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 153 Austria pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 154 Poland pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 155 Poland pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 156 Poland pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 157 Poland pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 158 Poland pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 159 Poland pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 160 Poland pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 161 Poland pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 162 Asia Pacific pet cancer therapeutics market, by country, 2018 - 2022, (USD Million)
• TABLE 163 Asia Pacific pet cancer therapeutics market, by country, 2023 - 2032, (USD Million)
• TABLE 164 Asia Pacific pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 165 Asia Pacific pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 166 Asia Pacific pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 167 Asia Pacific pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 168 Asia Pacific pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 169 Asia Pacific pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 170 Asia Pacific pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 171 Asia Pacific pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 172 China pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 173 China pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 174 China pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 175 China pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 176 China pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 177 China pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 178 China pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 179 China pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 180 India pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 181 India pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 182 India pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 183 India pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 184 India pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 185 India pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 186 India pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 187 India pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 188 Japan pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 189 Japan pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 190 Japan pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 191 Japan pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 192 Japan pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 193 Japan pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 194 Japan pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 195 Japan pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 196 Australia pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 197 Australia pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 198 Australia pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 199 Australia pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 200 Australia pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 201 Australia pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 202 Australia pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 203 Latin America pet cancer therapeutics market, by country, 2018 - 2022, (USD Million)
• TABLE 204 Latin America pet cancer therapeutics market, by country, 2023 - 2032, (USD Million)
• TABLE 205 Latin America pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 206 Latin America pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 207 Latin America pet cancer therapeutics market, by route of administration, 2018-2022, (USD Million)
• TABLE 208 Latin America pet cancer therapeutics market, by route of administration, 2023-2032, (USD Million)
• TABLE 209 Latin America pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 210 Latin America pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 211 Latin America pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 212 Latin America pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 213 Brazil pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 214 Brazil pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 215 Brazil pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 216 Brazil pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 217 Brazil pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 218 Brazil pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 219 Brazil pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 220 Brazil pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 221 Mexico pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 222 Mexico pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 223 Mexico pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 224 Mexico pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 225 Mexico pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 226 Mexico pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 227 Mexico pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 228 Mexico pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)

Charts & Figures

• FIG. 1 GMI Report Coverage: Critical research elements
• FIG. 2 Top-down approach
• FIG. 3 Breakdown of primary participants
• FIG. 4 Pet cancer therapeutics market industry 360 degree synopsis, 2018 - 2032
• FIG. 5 Industry landscape, 2018 - 2032 (USD Million)
• FIG. 6 Growth potential analysis, by therapy
• FIG. 7 Growth potential analysis, by route of administration
• FIG. 8 Growth potential analysis, by species
• FIG. 9 Growth potential analysis, by application
• FIG. 9 Gap analysis
• FIG. 10 Porter's analysis
• FIG. 11 PESTEL analysis
• FIG. 12 Company matrix analysis, 2021
• FIG. 13 Strategy dashboard, 2021